经内镜鼻胆管引流对接受经内镜逆行胰胆管造影的胆总管结石患者并发术后胰腺炎的预防效果观察

赵孝文; 鲍峻峻; 胡翠; 丁浩; 徐张巍; 刘晓昌; 梅俏; 许建明

doi:10.3969/j.issn.1001-5256.2014.08.012

经内镜鼻胆管引流对接受经内镜逆行胰胆管造影的胆总管结石患者并发术后胰腺炎的预防效果观察

DOI: 10.3969/j.issn.1001-5256.2014.08.012

1. 安徽医科大学第一附属医院消化内科
2. 安徽医科大学第一附属医院腔镜中心

详细信息

中图分类号: R657.4
计量
- 文章访问数: 2891
- HTML全文浏览量: 13
- PDF下载量: 520
- 被引次数: 0
出版历程
- 收稿日期: 2014-03-17
- 出版日期: 2014-08-20

Clinical effect of endoscopic nasobiliary drainage in prevention of post- ERCP pancreatitis in patients with choledocholithiasis

Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University

摘要

摘要: 目的探讨经内镜鼻胆管引流（ENBD）预防胆总管结石经内镜逆行胰胆管造影（ERCP）术后胰腺炎（PEP）及高淀粉酶血症的临床作用。方法收集2010年10月-2013年12月行ERCP取石治疗的胆总管结石患者560例,根据术中是否放置鼻胆管分为ENBD组（试验组）371例和非ENBD组（对照组）189例,观察术后3、24 h血清淀粉酶水平及PEP和高淀粉酶血症的发生率。两组间计量资料的比较采用t检验,率的比较采用卡方检验。结果试验组PEP及高淀粉酶血症发生率分别为8.1%（30/371）和13.7%（51/371）,显著低于对照组13.8%（26/189）（χ2=4.47,P=0.034）和21.2%（40/189）（χ2=5.06,P=0.024）。试验组患者术后3及24 h血清淀粉酶值分别为（215.34±304.00）U/L、（199.38±273.32）U/L,显著低于对照组（283.28±261.76）U/L、（257.05±199.25）U/L,差异有统计学意义（t=2.61、2.57,P均=0.01）。结论 ENBD可有效预防PEP及高淀粉酶血症的发生。
- 胆总管结石 /
- 胰腺炎 /
- 高淀粉酶血症 /
- 胰胆管造影术,内窥镜逆行 /
- 引流术
Abstract: Objective To investigate the clinical effect of endoscopic nasobiliary drainage (ENBD) in the prevention of post- endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) and hyperamylasemia in patients with choledocholithiasis.Methods A total of 560 patients with choledocholithiasis who underwent ERCP from October 2010 to December 2013 were included in the study.ENBD was performed in 371 patients (test group) , and the other 189 patients were designated as control group.Serum amylase level was measured at 3 and 24 h after ERCP, and the incidence of PEP and hyperamylasemia was determined.Comparison of continuous data between the two groups was made by t test, while comparison of rates was made by chi- square test.Results The incidence rates of PEP and hyperamylasemia in the test group were 8.1% (30 /371) and 13.7% (51 /371) , respectively, significantly lower than those in the control group (13.8%, 26/189;21.2%, 40/189) , (χ2= 4.47, P = 0.034;χ2= 5.06, P = 0.024) .The serum amylase levels at 3 and 24 h after ERCP in the test group were 215.34 ± 304.00 U /L and 199.38 ± 273.32 U /L, respectively, significantly lower those in the control group (283.28 ±261.76 U/L and 257.05 ±199.25 U/L) (t =2.61, P =0.01;t =2.57, P =0.01) .Conclusion ENBD can effectively reduce the incidence of PEP and hyperamylasemia in patients with choledocholithiasis.
- choledocholithiasis /
- pancreatitis /
- hyperamylasemia /
- cholangiopancreatography, endoscopic retrograde /
- drainage

HTML全文

参考文献(21)

[1]FREEMAN ML, GUDA NM.Prevention of post-ERCP pancreatitis:a comprehensive review[J].Gastrointest Endosc, 2004, 59 (7) :845-864.

[2]RABENSTEIN T, HAHN EG.Post-ERCP pancreatitis:new momentum[J].Endoscopy, 2002, 34 (4) :325-329.

[3]SHERMAN S.ERCP and endoscopic sphincterotomy-induced pancreatitis[J].Am J Gastroenterol, 1994, 89 (3) :303-305.

[4]JOHNSON GK, GEENEN JE, JOHANSON JF, et al.Evaluation of post-ERCP pancreatitis:potential causes noted during controlled study of differing contrast media.Midwest Pancreaticobiliary Study Group[J].Gastrointest Endosc, 1997, 46 (3) :217-222.

[5]SHERMAN S, HAWES RH, TROIANO FP, et al.Pancreatitis following bile duct sphincter of Oddi manometry:utility of the aspirating catheter[J].Gastrointest Endosc, 1992, 38 (3) :347-350.

[6]RATANI RS, MILLS TN, AINLEY CC, et al.Electrophysical factors influencing endoscopic sphincterotomy[J].Gastrointest Endosc, 1999, 49 (1) :43-52.

[7] COTTON PB, LEHMAN G, VENNES J, et al.Endoscopic sphincterotomy complications and their management:an attempt at consensus[J].Gastrointest Endosc, 1991, 37 (3) :383-393.

[8]DING X, CHEN M, HUANG S, et al.Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis:a meta-analysis[J].Gastrointest Endosc, 2012, 76 (6) :1152-1159.

[9] KISLI E, BASER M, AYDIN M, et al.The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis[J].Hepatogastroenterology, 2007, 54 (73) :250-253.

[10]BENVENUTI S, ZANCANELLA L, PIAZZI L, et al.Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate:a randomized placebo controlled multicenter study[J].Dig Liver Dis, 2006, 38 (Suppl 1) :s15.

[11]MOSLER P, SHERMAN S, MARKS J, et al.Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis[J].Gastrointest Endosc, 2005, 62 (2) :245-250.

[12]UEKI T, OTANI K, KAWAMOTO K, et al.Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis:a prospective, randomized trial[J].J Gastroenterol, 2007, 42 (2) :161-167.

[13]RABENSTEIN T, FISCHER B, WIESSNER V, et al.Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis[J].Gastrointest Endosc, 2004, 59 (6) :606-613.

[14]MORETOM, ZABALLA M, CASADO I, et al.Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis:A randomized double-blind trial[J].Gastrointest Endosc, 2003, 57 (1) :1-7.

[15]KAWAGUCHI Y, OGAWA M, OMATA F, et al.Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography[J].World J Gastroenterol, 2012, 18 (14) :1635-1641.

[16]SINGH P, DAS A, ISENBERG G, et al.Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis?A meta-analysis of controlled trials[J].Gastrointest Endosc, 2004, 60 (4) :544-550.

[17]FAZEL A, QUADRI A, CATALANO MF, et al.Does a pancreatic duct stent prevent post-ERCP pancreatitis?A prospective randomized study[J].Gastrointest Endosc, 2003, 57 (3) :291-294.

[18]TSUCHIYA T, ITOI T, SOFUNI A, et al.Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis:a preliminary, single-center, randomized controlled trial[J].J Hepatobiliary Pancreat Surg, 2007, 14 (3) :302-307.

[19]YANG J, PENG JY, PANG EJ, et al.Efficacy of endoscopic nasobiliary drainage for the prevention of post-endoscopic retrograde olangiopancreatography pancreatitis and cholangitis after repeated clearance of common bile duct stones:experience from a Chinese center[J].Dig Endosc, 2013, 25 (4) :453-458.

[20]SATO D, SHIBAHARA T, MIYAZAKI K, et al.Efficacy of endoscopic nasobiliary drainage for the prevention of pancreatitis after papillary balloon dilatation:a pilot study[J].Pancreas, 2005, 31 (1) :93-97.

[21]SONG LY, ZHAO QX, KONG XJ, et al.Efficacy of ENBD in the prevention of post-ERCP pancreatitis and hyperamylasemia in patients with common bile duct stones:an analysis of 65 cases[J].World J Gastroenterol, 2010, 18 (16) :1724-1727. (in Chinese) 宋丽亚, 赵清喜, 孔心涓, 等.ENBD预防胆管多发结石ERCP术后急性胰腺炎及高淀粉酶血症65例[J].世界华人消化杂志, 2010, 18 (16) :1724-1727.

施引文献

资源附件(0)

访问统计